FDA Approved: NEXTSTELLIS — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for Nextstellis (DROSPIRENONE AND ESTETROL) filed by Mayne Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• NEXTSTELLIS (DROSPIRENONE AND ESTETROL)

Snippet

SUPPL AP for NEXTSTELLIS (DROSPIRENONE AND ESTETROL)